These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 36564450)

  • 1. Busting the myth of methotrexate chronic hepatotoxicity.
    Di Martino V; Verhoeven DW; Verhoeven F; Aubin F; Avouac J; Vuitton L; Lioté F; Thévenot T; Wendling D
    Nat Rev Rheumatol; 2023 Feb; 19(2):96-110. PubMed ID: 36564450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methotrexate Hepatotoxicity and the Impact of Nonalcoholic Fatty Liver Disease.
    Shetty A; Cho W; Alazawi W; Syn WK
    Am J Med Sci; 2017 Aug; 354(2):172-181. PubMed ID: 28864376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Methotrexate, liver and rheumatoid arthritis in tropical areas].
    Diouf ML; Diallo S; Mbengue M; Moreira-Diop T
    Sante; 2001; 11(3):195-200. PubMed ID: 11641084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pragmatic non-invasive assessment of liver fibrosis in patients with psoriasis, rheumatoid arthritis or Crohn's disease receiving methotrexate therapy.
    Cervoni JP; Alby-Lepresle B; Weil D; Zhong P; Aubin F; Wendling D; Toussirot E; Vuitton L; Carbonnel F; Blondet R; Thévenot T; Calès P; Monnet E; Di Martino V
    Clin Res Hepatol Gastroenterol; 2020; 44S():100003. PubMed ID: 33602481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between cumulative methotrexate dose, non-invasive scoring system and hepatic fibrosis detected by Fibroscan in rheumatoid arthritis patients receiving methotrexate.
    Lertnawapan R; Chonprasertsuk S; Siramolpiwat S
    Int J Rheum Dis; 2019 Feb; 22(2):214-221. PubMed ID: 30565876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibrosing cholestatic hepatitis after methotrexate and prednisone therapy for rheumatoid arthritis.
    Topaloğlu S; Çalık A; Kalaycı O; Çeşmecioğlu E; Çobanoğlu Ü; Uzun Y
    Exp Clin Transplant; 2014 Mar; 12 Suppl 1():95-7. PubMed ID: 24635802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methotrexate-associated hepatotoxicity: retrospective analysis of 210 patients with rheumatoid arthritis.
    Shergy WJ; Polisson RP; Caldwell DS; Rice JR; Pisetsky DS; Allen NB
    Am J Med; 1988 Dec; 85(6):771-4. PubMed ID: 3195601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatotoxicity of methotrexate in rheumatic diseases.
    Kevat S; Ahern M; Hall P
    Med Toxicol Adverse Drug Exp; 1988; 3(3):197-208. PubMed ID: 3041245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methotrexate hepatotoxicity in children with leukemia.
    McIntosh S; Davidson DL; O'Brien RT; Pearson HA
    J Pediatr; 1977 Jun; 90(6):1019-21. PubMed ID: 870655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic effects of long-term methotrexate use in the treatment of inflammatory bowel disease.
    Te HS; Schiano TD; Kuan SF; Hanauer SB; Conjeevaram HS; Baker AL
    Am J Gastroenterol; 2000 Nov; 95(11):3150-6. PubMed ID: 11095334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amiodarone-induced reversible and irreversible hepatotoxicity: two case reports.
    Tsuda T; Tada H; Tanaka Y; Nishida N; Yoshida T; Sawada T; Sakata K; Hayashi K; Kawashiri MA; Oyama T; Sasaki M; Kurose N; Yamagishi M
    J Med Case Rep; 2018 Apr; 12(1):95. PubMed ID: 29653592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring liver function during methotrexate therapy for psoriasis: are routine biopsies really necessary?
    Thomas JA; Aithal GP
    Am J Clin Dermatol; 2005; 6(6):357-63. PubMed ID: 16343024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validity of noninvasive markers of methotrexate-induced hepatotoxicity: a retrospective cohort study.
    Martyn-Simmons CL; Rosenberg WM; Cross R; Wong T; Smith CH; Barker JN
    Br J Dermatol; 2014 Aug; 171(2):267-73. PubMed ID: 24942271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review of existing evidence demonstrates that methotrexate does not cause liver fibrosis.
    Cheema HI; Haselow D; Dranoff JA
    J Investig Med; 2022 Oct; 70(7):1452-1460. PubMed ID: 36002175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methotrexate hepatotoxicity.
    West SG
    Rheum Dis Clin North Am; 1997 Nov; 23(4):883-915. PubMed ID: 9361160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatotoxicity of prolonged methotrexate therapy for rheumatoid arthritis.
    Mackenzie AH
    Cleve Clin Q; 1985; 52(2):129-35. PubMed ID: 4028418
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of methods for identifying early methotrexate-induced hepatotoxicity in patients with rheumatoid arthritis.
    Arias JM; Morton KA; Albro JE; Patch GG; Valdivia S; Greenberg HE; Christian PE; Datz FL
    J Nucl Med; 1993 Nov; 34(11):1905-9. PubMed ID: 8229232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. "Hepatic toxicity by methotrexate with weekly single doses associated with folic acid in rheumatoid and psoriatic arthritis. What is its real frequency?".
    García DS; Saturansky EI; Poncino D; Martínez-Artola Y; Rosenberg S; Abritta G; Ascimani-Peña C; Cravero A
    Ann Hepatol; 2019; 18(5):765-769. PubMed ID: 31105018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatotoxicity of long-term methotrexate therapy for psoriasis.
    Tobias H; Auerbach R
    Arch Intern Med; 1973 Sep; 132(3):391-6. PubMed ID: 4783020
    [No Abstract]   [Full Text] [Related]  

  • 20. Methotrexate Hepatotoxicity Monitoring Guidelines in Psoriasis and Rheumatoid Arthritis: Is There a Consensus?
    Clary DD; Reid AT; Kiani R; Fanciullo J
    S D Med; 2021 Aug; 74(8):363-366. PubMed ID: 34461001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.